Jenapharm Gmbh

Theodor Hermann Lippert

Michael Oettel

Michael Dittgen

Sabine Fricke

Hermann Osterwald

Thomas Gr&auml;ser

The use of melatonin for the production of peroral pulsatile forms of medications assures the safeguard of an effective level of the medical substance of melatonin in the blood, and which realize a relatively short invasion phase with a controlled delivery in comparison to conventional forms of medication containing melatonin, and which simultaneously exclude the known side effects. A control of the delivery of the melatonin is effected which is associated with the precise adaptation to the illness episodes or the pain attacks of certain illnesses, which can be treated prophylactically and therapeutically with the active agent melatonin.

Growing community of inventors

Munich, Georgia

Theodor Hermann Lippert